Jason Wittes

Stock Analyst at Roth MKM

(1.2)
# 2082
Out of 5,441 analysts
63
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
SYK Stryker
Maintains: Strong Buy
405 456
376.68 21.06% 11 May 2, 2025
ALUR Allurion Technologie...
Reiterates: Buy
16 16
2.63 508.37% 2 Mar 21, 2025
MGRM Monogram Technologie...
Maintains: Strong Buy
4 6
5.39 0.19% 2 Mar 18, 2025
FBIO Fortress Biotech
Reiterates: Strong Buy
15 16
1.92 733.33% 3 Mar 11, 2025
OFIX Orthofix Medical
Reiterates: Buy
22 22
12.95 69.88% 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
60 72
69.99 2.87% 3 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
3.53 211.61% 2 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
100 115
59.45 93.44% 4 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 36
9.98 260.72% 1 Jul 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
11
7.87 39.77% 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.01 890.1% 1 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
100
92.59 8% 1 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
2.54 96.85% 4 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.35 566.67% 2 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
28.13 166.62% 2 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
15.31 43.7% 3 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
120
100.02 19.98% 7 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
206
147.42 39.74% 1 Sep 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
145
201.59 -28.07% 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
12.06 24.38% 2 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
10.91 1733.18% 3 Feb 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
42
n/a n/a 1 Jul 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
26.4 -1.52% 1 Feb 22, 2017